Thursday | 8 January, 2009
Stories about: MPA Systems
- +
Prana to conduct Swedish trials of potential Alzheimer's treatment 05/10/2006 11:16:09
Melbourne-based Prana Biotechnology has announced that it has received regulatory approval from Sweden's Medical Products Agency (MPA) to start a Phase IIa clinical trial of its proprietary lead compound, PBT2, in patients with early Alzheimer's disease.
Additional Resources
Newsletter Subscription
Australian Life Scientist Member Login
Fujitsu Introduces First Netbook Series – Fujitsu M1010, the Comprehensive Solution for Work and Play. 2008-12-15 16:30:00+11
Kingston Technology Boosts DataTraveler 150 Capacity to 64GB 2008-12-09 15:30:00+11
IDC Says Asia/Pacific Excluding Japan IT Market Will Remain The Bright Spot... 2008-12-04 15:04:00+11
AOC Launches 18.5” Widescreen Green 16:9 LCD Monitor in Australia and New Zealand 2008-12-03 15:30:00+11
NComputing Appoints Country Manager for Australia, New Zealand, and South Pacific Islands 2008-12-03 00:43:00+11
Sponsored Links
Subscribe to Australian Life Scientist
Australian Life Scientist is Australia's leading magazine for the life sciences sector.
